Wisconsin’s biotech executives are more bullish on their own companies than on the state’s overall biotech economy, according to a new quarterly survey from the Wisconsin Biotechnology and Medical Device Association and the state Department of Commerce.
More than 70 percent of the executives who responded to the inaugural Wisconsin BioIndustry Outlook survey rated the current condition of the state’s biotech and medical device industry as excellent or good, and they were almost evenly split on whether the state of the industry would get better or stay the same during the next 12 months.